|Home | About | Journals | Submit | Contact Us | Français|
Serious medication errors occur commonly in the period after hospital discharge. Medication reconciliation in the postdischarge ambulatory setting may be one way to reduce the frequency of these errors. The authors describe the design and implementation of a novel tool built into an ambulatory electronic medical record (EMR) to facilitate postdischarge medication reconciliation. The tool compares the preadmission medication list within the ambulatory EMR to the hospital discharge medication list, highlights all changes, and allows the EMR medication list to be easily updated. As might be expected for a novel tool intended for use in a minority of visits, use of the tool was low at first: 20% of applicable patient visits within 30 days of discharge. Clinician outreach, education, and a pop-up reminder succeeded in increasing use to 41% of applicable visits. Review of feedback identified several usability issues that will inform subsequent versions of the tool and provide generalizable lessons for how best to design medication reconciliation tools for this setting.
Unintentional medication discrepancies, defined as unexplained differences in documented regimens across different sites of care,1 2 represent an important cause of adverse drug events (ADEs) among hospitalized and recently discharged patients.3–5 One possible way to prevent these discrepancies is medication reconciliation, ‘a process of identifying the most accurate list of all medications a patient is taking… and using this list to provide correct medications for patients anywhere within the healthcare system.’6 Initially driven in part by The Joint Commission's National Patient Safety Goal,7 most medication reconciliation efforts to date have focused on the inpatient setting. However, medication reconciliation needs to continue after the patient is discharged, and in fact, such reconciliation may be as or more important than inpatient reconciliation efforts, for the following reasons:
Some new electronic inpatient medication reconciliation tools now automatically replace the ambulatory EMR medication list with hospital discharge medication orders.9 This may actually cause more problems than it solves because it removes the PCP from the reconciliation process and fails to address any of the above issues.
To facilitate postdischarge medication reconciliation, Partners Healthcare designed and built a new tool within the ambulatory EMR. As part of a federally funded cluster-randomized controlled trial (clinicaltrials.gov identifier NCT00740675), the tool was implemented in 10 primary-care practices affiliated with Brigham and Women's Hospital (BWH) and Massachusetts General Hospital (MGH). This manuscript describes the design and implementation of the tool, attempts to improve use, informal feedback on the tool from clinicians, and generalizable lessons learned to maximize the usability of the tool and its impact on patient safety.
The Partners PostDischarge Medication Reconciliation Tool was created in 2007 within the Longitudinal Medical Record (LMR), an internally developed, CCHIT-certified EMR used within Partners Healthcare.10 Efforts to design the tool began in 2004, when Partners Information Systems gathered requirements, and collected and analyzed use cases. Once the necessary features and functions were agreed upon (eg, access to the discharge summary with a single click, integration with existing EMR medication alerts, access to formulary information, separation of reconciliation from prescription writing), low-fidelity prototypes of the user interface were constructed in HTML. The graphic user interface was demonstrated to stakeholder groups and iteratively improved based on feedback.
The medication reconciliation tool relies on services provided by Partners Enterprise Medication Decision Support Services (EMEDS). The main service can compare any two medication lists, classify medications (using EMEDS mappings and the First DataBank (South San Francisco, California) classification scheme), and report differences.
The tool is accessible for 6 months after a patient is discharged from BWH or MGH, or until the reconciliation process is complete and is accessed by clicking on a pink ‘Discharge Reconciliation’ button within the EMR main Medications screen. The tool presents the EMR medication list (ie, as it existed prior to hospital admission) and the discharge medication regimen side by side, with all medications sorted by class, identical medications displayed next to each other, and all differences in dose or frequency highlighted (figure 1).
A change to the ambulatory EMR medication list can be made with a single click using one of three action buttons (figure 1):
Note that different medications in the same therapeutic class are near each other (although not directly across from each other); making such a change to the EMR requires both adding the discharge medication and deleting the preadmission EMR medication.
One conscious design decision was to not require that every medication be acted upon (eg, accepted, rejected, or modified) by the user. Rather, if a medication is already accurate in the EMR list, nothing need be done. This approach minimizes the amount of work required by the user to reconcile medications. However, as noted below, this decision did cause some confusion among users.
Once a user is done, s/he may select ‘Reconcile in Full’ or ‘Reconcile in Part.’ Partial reconciliation was designed primarily for specialists who may prescribe only a subset of a patient's medication regimen (eg, a rheumatologist who prescribes methotrexate but none of the other medications a patient takes). Partial reconciliation does not turn off the ‘Discharge Reconciliation’ button on the main Medication Reconciliation screen and allows the patient's PCP to complete reconciliation at a future date. PCPs were expected to reconcile medications in full under most circumstances. Users then sign the changes they made to the EMR medication list and continue their other tasks.
To evaluate this new tool, we implemented it at 10 primary care practices, five each affiliated with BWH and MGH, involving 103 PCPs. Each intervention practice was visited by one of the study authors, who demonstrated use of the tool. In addition, each PCP in these practices received periodic emails reminding them to use it, reviewing instructions for use, and providing tips. In the tool itself, users could also access an animated demonstration of the application, created using RoboDemo software (Macromedia, San Francisco, California).
In the first 6 months of the trial, use of the tool was low (table 1). Of 1114 patients hospitalized at BWH and MGH with a PCP appointment in any of the intervention practices within 30 days of discharge, the tool was used in only 198 patients (18%), despite an average of 1.7 visits to PCPs during that period, and during the first 10 days after discharge, the tool was used in only 12% of patients.
We hypothesized several possible reasons for the low rate of use:
To determine which of these factors were most important, we sent three different email surveys to study PCPs, one each to three different types of users (never users, those who used it once or twice, and more frequent users). For example, for never users, using partially open-ended questions, we asked whether any of the following issues were applicable: the PCP had not seen a patient in the office within 30 days of discharge, training in use of the tool was inadequate, the PCP forgot to use the module when seeing recently discharged patients in the office, or other reasons. The surveys revealed the following:
Several other usability issues surfaced as a result of our surveys:
We took several actions in response to these results. First, we returned to each of the intervention practices to review use of the tool, emphasizing that not every medication needed to be acted upon. This educational outreach was accompanied by new emails to providers explaining how the tool worked and providing examples. We also removed the pop-up reminder alerting users to remaining discrepancies at the time of signing. As of the conclusion of the study, in June 2009, users still could not indicate that reconciliation was complete if no changes were made to the EMR medication list.
To deal with the issue of users forgetting to use the tool, in March 2009, we automated email reminders about using the tool to PCPs of intervention practices on the morning they were scheduled to see a recently discharged patient. More importantly, starting in June 2009, we modified the EMR to provide two different reminders regarding postdischarge medication reconciliation:
Table 2 lists all usability issues discovered during the study and proposed or enacted changes to manage them.
As a result of these efforts, use of the tool in eligible patients increased steadily during the last 6 months of the study (table 1). During the last 2 months of the study, July–August 2009, the tool was used in 41% of eligible patients.
This paper describes a novel approach to facilitate medication reconciliation by ambulatory providers in recently discharged patients. Many PCPs likely do this process manually; our postdischarge medication reconciliation tool, built into the EMR, compares and contrasts preadmission and postdischarge regimens in a way that should make the process easier and safer. In contrast to many other automated approaches, our postdischarge medication reconciliation tool still actively involves the PCP in the medication reconciliation process, involvement that we believe is critical for patient safety.
We noted several barriers to use, some unique to the way our EMR and the tool were designed, but most generalizable. Because this is a new process for most EMRs and is meant to be used in a minority of patients visiting on a given day, it is likely that an active reminder system is needed for applicable patient visits. A high degree of clarity and transparency is essential, regarding whether or not explicit decisions are required for every medication discrepancy. A requirement to document every decision would likely take more time to use but may in fact be less confusing to users and could result in fewer downstream errors. Lastly, differences in e-prescribing formats in inpatient versus outpatient pharmacies also need to be considered.
As a result of our study, several additional changes to our tool have already been undertaken or are planned:
This study had several limitations. It was carried out at 10 practices within an integrated delivery system affiliated with two academic medical centers, and the results therefore may not be generalizable to other centers or practice types.
We developed a tool to enable postdischarge medication reconciliation. This reconciliation—though required by the Joint Commission—can be challenging to accomplish, especially for patients taking large numbers of medications. Development and evaluation of our tool identified a number of important issues and lessons learned that we hope will be valuable to others in their efforts to improve patient safety during the transition from the inpatient to the ambulatory setting.
We would like to thank L Seefeld, G Biedron and J Budris for research assistance and H Ramelson for LMR project management. Portions of this paper were presented at an AHRQ Works in Progress webinar on May 12, 2009 and at Massachusetts General Hospital Primary Care Grand Rounds, Boston, Massachusetts, April 23, 2010.
Funding: This study was supported by a grant from the Agency for Healthcare Research and Quality (1 U18 HS016970-01). JLS was supported by a mentored career development award from the National Heart Lung and Blood Institute (1 K08 HL072806-01).
Competing interests: None.
Provenance and peer review: Not commissioned; externally peer reviewed.